Stakeholders want update notifications sent only when a change has been made to factual information. Changes to the subscribed item that typically don’t warrant an update notification include fixing a typo; changing administrative metadata such as Title or Creator; added or deleted Item Relationships.
Do you want to notify subcribers that this content has changed?
If yes, enter any specific comments you want to send to subscribers in this notification:
Select whomever you wish to assign this item to by clicking the checkbox next to the users name below. You can select all users in the next role by clicking the select all checkbox.
You may enter an additional comment below. If you are rejecting the item, you must include a comment.
For more information
Johns Hopkins University. Oral N-acetylcysteine for Retinitis Pigmentosa (NAC Attack). ClinicalTrials.gov.
Campochiaro PA, et al. The mechanism of cone cell death in retinitis pigmentosa. Progress in Retinal and Eye Research. 2018;62:24.
Campochiaro PA, et al. Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase 1 trial. Journal of Clinical Investigation. 2020;130:1527.
Applied Genetic Technologies Corp. A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations. ClinicalTrials.gov.
JAEB Center for Health Research. Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants (Uni-Rare). ClinicalTrials.gov.